What is a potential risk associated with the use of Medroxyprogesterone?

• A. Increased risk of urinary tract infections
• B. Potential hormonal imbalance
• C. Pulmonary complications
• D. Elevated blood pressure

Answer: (D)

Medroxyprogesterone, a progestin used in various hormonal therapies, including contraception and treatment of endometriosis, has been associated with elevated blood pressure in some patients. This risk stems from the hormonal effects of progestins, which can influence the vascular system and fluid retention, thereby affecting blood pressure levels. While the elevation in blood pressure may not occur in everyone, it is significant enough that patients using medroxyprogesterone often require monitoring for this potential side effect, especially in those with existing hypertension or other cardiovascular risk factors.

The importance of recognizing elevated blood pressure as a potential risk with medroxyprogesterone lies in the need for healthcare providers to educate patients about the importance of monitoring their blood pressure during treatment. This aids in prompt identification and management of any adverse effects, ensuring the safe use of the medication.